Rafferty Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-276,787
| Closed | -$7.46M | – | 1177 |
|
2022
Q4 | $7.46M | Buy |
276,787
+114,534
| +71% | +$3.09M | 0.06% | 282 |
|
2022
Q3 | $2.91M | Buy |
162,253
+56,882
| +54% | +$1.02M | 0.03% | 423 |
|
2022
Q2 | $1.31M | Sell |
105,371
-165,686
| -61% | -$2.06M | 0.01% | 569 |
|
2022
Q1 | $3.61M | Buy |
271,057
+18,867
| +7% | +$251K | 0.02% | 457 |
|
2021
Q4 | $3.93M | Buy |
252,190
+138,428
| +122% | +$2.16M | 0.02% | 469 |
|
2021
Q3 | $2.55M | Sell |
113,762
-1,657
| -1% | -$37.2K | 0.02% | 558 |
|
2021
Q2 | $2.63M | Buy |
+115,419
| New | +$2.63M | 0.02% | 565 |
|